The component of Lipitor is atorvastatin, a member of the drug class known as statins, which are used primarily for the treatment of dyslipidemia and for the prevention of cardiovascular disease. This medicine is a selective HMG-CoA reductase inhibitor. It lowers the plasma cholesterol by inhibiting HMG-CoA reductase in the liver tissue and hepatic cholesterol biosynthesis, increases the synthesis of low-density lipoprotein receptors (LDL receptors), and reduces the level of low lipoprotein to decrease the production of cholesterol in the body. It may also play a plaque-stabilizing role and also have anti-inflammatory effects and other mechanisms in preventing stroke. As the synthesis of cholesterol is essential for the normal function of neurons, using statins may generate cognitive disorders, such as memory loss and confusion. The symptoms are generally not serious and are reversible on cessation of drug treatment. Although the risk exists, FDA still concludes that the advantages of statins are greater than the disadvantages in the treatment of cardiovascular disease. The side effects of Lipitor include headache, diarrhea, vomiting, flatulence, and constipation, and the more serious side effects can be abnormal muscle pain, muscle cramps or unusual tiredness or weakness, and yellowing of the skin or the whites of the eyes, and lower back pain or allergic skin reactions, etc. In 1989, Mr. Yuan Lin discovered the Absolutely Constant Energy Source (ACES). He can utilize ACES to activate the genome responsible for inheritance, development and performance of body functions in the human body to control specific amino acid sequences and protein peptide chain formation processes, directing cell division, replication and new organelle formation. ACES was also applied to induce changes in the irreversible process of spontaneous biochemical reactions of carbohydrates, lipids, proteins, amino acids, enzymes, nucleic acids, vitamins, hormones, and trace elements. Mr. Yuan Lin thus had his body experience an unprecedented leap forward in human evolution, which has thoroughly changed the human biological form, structure, and habits inherited over billions of years, to become the first successfully-evolved New Human Line. The purpose of this experiment is to prove that Mr. Yuan Lin, the first successfully-evolved New Human Line, can utilize the Absolutely Constant Energy Source (ACES) to activate Lipitor and change its concentration without any change in its molecular weight, structural formula, and conformation, at 25℃, 1.0 atm, and pH 7.0, in a confined and isolated space, and with no contact with catalysts, biologically active substances, chemical substances, and physical action forces, and also, by means of changes in the concentration, to control the biochemical reactions induced by Lipitor so as to maximize its efficacy in the human body at the lowest dose, reduce or totally eliminate the side effects, and avoid adverse medical reactions.
Table 1. Comparison of the absorbance between two treatments at 266 nm From the above experimental results, we can see that there is significant difference (p=0.001) in the concentration between the control samples and the samples treated with ACES by Mr. Yuan Lin. It proved that Mr. Yuan Lin, the New Human Line, can utilize the Absolutely Constant Energy Source and the new biological engineering techniques to activate Lipitor and change its concentration, and also, by means of changes in the concentration, to control the biochemical reactions induced by Lipitor so as to maximize its efficacy in the human body at the lowest dose, reduce or totally eliminate the side effects and avoid adverse medical reactions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|